Trial Profile
Pharmacokinetics and Safety of Single Doses of Delafloxacin Administered Intravenously in Healthy Human Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jan 2016
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions; Pharmacokinetics
- 12 Dec 2015 Results of this study and other two studies (n=94) published in the Clinical Therapeutics
- 10 Oct 2011 New trial record